Your browser doesn't support javascript.
loading
The use of skin models in drug development.
Mathes, Stephanie H; Ruffner, Heinz; Graf-Hausner, Ursula.
Affiliation
  • Mathes SH; Institute of Chemistry and Biological Chemistry, Zurich University of Applied Sciences (ZHAW), Einsiedlerstrasse 31, 8820 Waedenswil, Switzerland.
  • Ruffner H; Developmental and Molecular Pathways (DMP), Novartis Institutes for BioMedical Research (NIBR), Fabrikstrasse 22, 4056 Basel, Switzerland.
  • Graf-Hausner U; Institute of Chemistry and Biological Chemistry, Zurich University of Applied Sciences (ZHAW), Einsiedlerstrasse 31, 8820 Waedenswil, Switzerland. Electronic address: ursula.graf@zhaw.ch.
Adv Drug Deliv Rev ; 69-70: 81-102, 2014 Apr.
Article in En | MEDLINE | ID: mdl-24378581
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Diseases / Skin Physiological Phenomena / Dermatologic Agents / Drug Discovery / Models, Biological Limits: Animals / Humans Language: En Journal: Adv Drug Deliv Rev Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2014 Type: Article Affiliation country: Switzerland
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Diseases / Skin Physiological Phenomena / Dermatologic Agents / Drug Discovery / Models, Biological Limits: Animals / Humans Language: En Journal: Adv Drug Deliv Rev Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2014 Type: Article Affiliation country: Switzerland